CCL7 and atherosclerosis: Some previous studies suggested the potential beneficial effects of CCL7 inhibition by neutralizing antibody or genetic knockout in myocardial infarction, atherosclerosis, aortic aneurysm, acute kidney injury, and in later stages of unilateral ureteral obstruction [27, 29, 42, 69, 72].